SENEXON-S

Product NDC: 0536-4086
Requested package NDC: 0536-4086-10
11-digit product format: 005364086
Labeler code: 0536
Product ID: 0536-4086_aaa2cb99-378e-74e8-e053-2a95a90aa2d6
Type: HUMAN OTC DRUG
Nonproprietary name: DOCUSATE SODIUM -SENNOSIDES
Dosage form: TABLET, COATED
Route: ORAL
Labeler: RUGBY LABORATORIES, INC.
Application: part334
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2011-03-16
Marketing end: 0000-00-00
Substance: DOCUSATE SODIUM; SENNOSIDES A AND B
Active strength: 50 mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0536-4086	0536-4086-10	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0536-4086-01	EA - Each	0536-4086	af38146a-a60f-4c1c-9038-38a930152ea6	1	2012-07-24
0536-4086-10	EA - Each	0536-4086	eb55d6fe-9265-49bf-8f42-35b29c4f319f	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
SENNOSIDES A AND B	ACTIVE INGREDIENT	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
DOCUSATE	ACTIVE MOIETY	M7P27195AG	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
SENNOSIDES A AND B	ACTIVE MOIETY	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	SENEXON-S (DOCUSATE SODIUM-SENNOSIDES TABLET) TABLET, COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	6
docusate sodium	ACTIVE INGREDIENT	F05Q2T2JA0	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
sennosides a and b	ACTIVE INGREDIENT	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
docusate	ACTIVE MOIETY	M7P27195AG	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
sennosides a and b	ACTIVE MOIETY	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
DIBASIC CALCIUM PHOSPHATE DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [RUGBY LABORATORIES, INC.]	3
docusate sodium	ACTIVE INGREDIENT	F05Q2T2JA0	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [H.J. HARKINS COMPANY, INC.]	2
sennosides a and b	ACTIVE INGREDIENT	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [H.J. HARKINS COMPANY, INC.]	2
docusate	ACTIVE MOIETY	M7P27195AG	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [H.J. HARKINS COMPANY, INC.]	2
sennosides a and b	ACTIVE MOIETY	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [H.J. HARKINS COMPANY, INC.]	2
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
docusate sodium	ACTIVE INGREDIENT	F05Q2T2JA0	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
sennosides a and b	ACTIVE INGREDIENT	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
SENNOSIDES A AND B	ACTIVE INGREDIENT	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
docusate	ACTIVE MOIETY	M7P27195AG	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
DOCUSATE	ACTIVE MOIETY	M7P27195AG	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
sennosides a and b	ACTIVE MOIETY	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
SENNOSIDES A AND B	ACTIVE MOIETY	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [PREFERRED PHARMACEUTICALS, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM
1B5FPI42EN	SENNOSIDES A AND B	62211-03-4	SENNOSIDES A AND B

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1248013	Senexon-S 50 MG / 8.6 MG Oral Tablet	PSN	f6e923e8-46e8-4287-bd62-5b954829cd73	2
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	f6e923e8-46e8-4287-bd62-5b954829cd73	2
1248013	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S]	SBD	f6e923e8-46e8-4287-bd62-5b954829cd73	2
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	f6e923e8-46e8-4287-bd62-5b954829cd73	2
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	f6e923e8-46e8-4287-bd62-5b954829cd73	2
1248013	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S]	SY	f6e923e8-46e8-4287-bd62-5b954829cd73	2
1248013	Senexon-S (docusate sodium 50 MG / sennosides, USP 8.6 MG) Oral Tablet	SY	f6e923e8-46e8-4287-bd62-5b954829cd73	2
1248013	Senexon-S 50 MG / 8.6 MG Oral Tablet	PSN	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
1248013	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S]	SBD	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
1248013	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S]	SY	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
1248013	Senexon-S (docusate sodium 50 MG / sennosides, USP 8.6 MG) Oral Tablet	SY	b3c26587-5b4b-4360-b491-6fde5a908c8b	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0536-4086-10	00536408610	1000 TABLET, COATED in 1 BOTTLE, PLASTIC (0536-4086-10)	2020-07-17	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
192R RUGBY SENEXON-S TABLETS 0536-4086	RUGBY LABORATORIES, INC. \| TIME-CAP LABS, INC	2020-07-17	HUMAN OTC DRUG LABEL	5
Docusate Sodium with Sennosides - PD-Rx Pharmaceuticals, Inc.	PD-Rx Pharmaceuticals, Inc.	2019-08-02	HUMAN OTC DRUG LABEL	6
SENEXON-S - Preferred Pharmaceuticals, Inc.	Preferred Pharmaceuticals, Inc.	2019-03-21	HUMAN OTC DRUG LABEL	4
Senexon S 50mg 8 6mg	NCS HealthCare of KY, Inc dba Vangard Labs	2017-01-19	HUMAN OTC DRUG LABEL	3
DOCUSATE SOD SENNA 50 8 6MG FOR RUGBY	Aidarex Pharmaceuticals LLC	2013-12-30	HUMAN OTC DRUG LABEL	1
Senexon-S Tablets	NCS HealthCare of KY, Inc dba Vangard Labs	2013-08-23	HUMAN OTC DRUG LABEL	6
SENEXON-S - H.J. Harkins Company, Inc. \| RUGBY LABORATORIES, INC. \| TIME-CAP LABS, INC	H.J. Harkins Company, Inc. \| RUGBY LABORATORIES, INC. \| TIME-CAP LABS, INC	2011-12-29	HUMAN OTC DRUG LABEL	2